Skip to main content
Journal of Public Health in Africa logoLink to Journal of Public Health in Africa
. 2011 Sep 5;2(2):e24. doi: 10.4081/jphia.2011.e24

Seroprevalence of Toxoplasma gondii infection among pregnant women in Cameroon

Anna L Njunda 1, Jules CN Assob 3, Dickson S Nsagha 2, Henri L Kamga 1, Peter F Nde 2, Vuchas C Yugah 1
PMCID: PMC5345497  PMID: 28299065

Abstract

Toxoplasmosis is caused by an intracellular protozoan, Toxoplasma gondii, which has a wide geographical distribution. The congenital form results in a gestational form that can present a temporary parasiteamia that will infect the fetus. For this reason early diagnosis in pregnancy is highly desirable, allowing prompt intervention in cases of infection. The aim of this study was to determine the seroprevalence of Toxoplasma gondii antibodies among pregnant women attending the Douala General Hospital. The study was carried out between March and July 2009, whereby 110 pregnant women were tested for IgG and IgM antibodies and information about eating habits and hygienic conditions was collected using a questionnaire. These women's ages ranged from 20–44 years old with an average of 29.9 years; the overall IgG and IgM seroprevalence was 70% and 2.73 % respectively. Seroprevalence was significantly high amongst women who ate raw vegetables (76.39%, P<0.05) and there was a significant trend towards a higher seroprevalence in women who did not have a good source of water (75.58%, P<0.05). This research showed that consumption of raw vegetables and poor quality drinking water are two risk factors associated with Toxoplasma gondii infection amongst pregnant women attending the Douala General Hospital in Cameroon.

Key words: toxoplasmosis, pregnancy, seroprevalence, risk factors, Douala, Cameroon.

Introduction

Discovered in 1908, toxoplasmosis is caused by an intracellular protozoan known as Toxoplasma gondii. It infects multiple of warm blooded animals including humans, livestock, birds etc, however cats, sheeps and pigs are the definitive hosts to Toxoplasma gondii. Toxoplasmosis has a wide geographical distribution. Although T. gondii infection in adults is usually asymptomatic or associated with self limited symptoms (e.g. fever, malaise, lym-phadenopathy), infection of humans occur either congenitally or by ingestion of foodstuffs contaminated by infected cat faeces, or lamb or pork contaminated with T. gondii cysts. Contamination of pregnant women may cause serious health problems if the parasite is transmitted to the foetus to cause congenital toxoplasmosis.1 The congenital form results in a severe systemic disease because if the mother is infected for the first time during gestation, she can present a temporary parasitemia that will infect the foetus. Many clinical symptoms are seen in congenitally infected children from a mild disease to serious signs such as mental retardation. Early diagnosis during pregnancy is highly desirable allowing prompt intervention in cases of infection through treatment in order to reduce the probability of foetal infection and consequent substantial damage to the foetus. Conventional tests for establishment of a foetus diagnosis of toxoplasmosis include options from serology to PCR. Prevention of human toxoplasmosis is based on care to avoid the infection, understanding the disease and serological exams during gestation. Pregnant women should be tested serologically from 3 months of gestation until one month after childbirth. Toxoplasma infection during pregnancy is widely treated with oral spiramycin to reduce the risk of congenital toxoplasmosis in the infant. Failures of therapy have been observed.2 Different serological tests often measure different antibodies that possess unique patterns of rise and fall with time after infection. A combination of serological tests is frequently required to establish whether an individual has been more likely infected in the distant past or has been recently infected.3 The prevalence rate of toxoplasmosis varies according to geographical location, age, gender of the population studied and other factors. In Europe, the prevalence rate ranges from 20% to 85%; in the United States, the prevalence is 12% to 41%,4 while in Cameroon is 48.5%.5 Prevalence in other countries can vary from 18% to 65%.6 The main objective of this study was to determine the seroprevalence and to assess some risk factors associated with Toxoplasma gondii amongst pregnant women who consulted at the Department of Gynaecology in the Douala General Hospital, Cameroon.

Materials and Methods

Materials

The study was carried out at the Douala General Hospital in the period March–July 2009. The study subjects comprised of pregnant women aged 18–45 years old sent to the laboratory of the Douala General Hospital by the Gynaecology Department for T. gondii antibodies screening. Douala serves as the economic capital of Cameroon. Its industrial, economic, commercial and educational services have accounted for the dense population found here. The population growth rate is estimated at 9.3%. The development of the town is uneven with a wide gap between the poor and the rich. Most of the poor do not have access to clean water and have resorted to wells, which are not often treated as their only source of water. There are problems of poor housing conditions, overcrowding, low family income coupled with poverty which have helped in the spread of many parasitic infections. This town has many hospitals, which are distributed evenly with 2 considered as reference hospitals; the General Hospital and Laquintinie Hospital, Douala.

Methods

Sampling and sample collection

Data was obtained through the filling of questionnaire. The questionnaire was designed and pretested at the antenatal clinic of the General Hospital annex of Buea in Cameroon. The atecubical vein of the forearms was selected and disinfected with 70% alcohol cotton wool swab. Venous blood was collected into a dry tube, which was labeled with the patients name and code. The sample was allowed to clot completely before centrifugation. After centrifugation, serum was separated from the clot into tightly closed storage tubes and stored at 2–8°C since tests were performed in batches once every week.

Laboratory methods

The platelia tm Toxo IgG TMB and IgM kits for the qualitative and quantitative detection of anti-T.gondii IgG and IgM in human serum by enzyme immunoassay was then used to analyse each sample.

Principle of Toxo lgG

The principle of this is a solid phase technique referred to as indirect ELISA. The T. gondii antigens used to coat the microplates were obtained from tachyzoites ultrasonic enriched with membrane proteins. The conjugate consist of a peroxydase labeled monoclonal antibody specific to human gamma chains. Reading is converted into IU/mL using a standard curve.

Principle of IgM

The test is an enzyme-linked immunosorbent assay (ELISA), the principle is based on the capture of the IgM on the solid phase. Anti-human antibodies are coated on the solid phase (wells of the microplate). A mixture of the T. gondii antigens and the monoclonal anti-T. gondii antibody labeled with peroxydase is used as the conjugate. The test uses the following steps.

Assay procedure

Generally, after enough samples have been collected, those in the freezer are removed and thawed at room temperature. These sera are then processed as described by the manufacturer (Human INC).

Interpretation of results for IgG

Detection of the lgG anti-T. gondii with Platelia Toxo lgG TMB provides the Patients with their immune status: i) titer<61 U/mL, non significant level of anti body – Absence of immunity; ii) 61 U/mL<Titer<91 U/mL, non significant level of antibody, the result of a single serum sample does not constitute sufficient proof for establishing the patient's immune status against T. gondii; iii) 91 U/mL<Titer<240 U/mL, significant level of antibody. Long standing immunity or early seroconversion; iv) titer≥240 U/mL, high levels of antibody. Recent seroconversion or persistently high level of immunity.

Data analyses

Data was entered into Microsoft Excel sheets and exported to Epi-Info for analysis using descriptive statistics. Statistical significance was set at 95% confidence interval (CI). At the initial step of the analyses, frequency distributions of each variable were produced and the information arranged according to age groups and risk factors.

Results

A total of 110 samples from pregnant women were analysed. These women's ages ranged from 20–44 years, with an average of 29.9 years. The prevalence of toxoplasmosis was 77 (70%) giving a 95% confidence interval of 61.4–78.6%. Among these women, 77 women were seropositive for IgG antibodies and 3 were seropositive for IgM antibodies giving a prevalence of 70% and 2.73%, respectively. Here, the various parameters analysed are shown on Tables 1 to 7. Percentages were used to express the prevalence rates.

Table 1. Frequency distribution of age groups of toxoplasmosis in pregnant women with respect to age.

T. gondii IgG
Age groups No of positives (%) No of negatives (%) Total (%)
20–25 16 (59.30) 11(40.70) 27 (24.50)
26–30 21 (70.00) 9 (30.00) 30 (27.30)
31–35 24 (70.60) 10 (29.40) 34 (30.90)
36–44 16 (84.20) 3(15.80) 19 (17.30)
Total 77 (70.00) 33 (30.00) 110 (100.00)

Table 7. Summary of risk factors to toxoplasmosis in pregnancy in the general Hospital Douala, Cameroon.

Risk factors Prevalence (%) Confidence interval (%)
Lower limit Upper limit
Age (31–35 years) 31.2 22.5 39.9
Cat ownership 72.6 64.3 80.9
No cat ownership 66.7 57.9 75.5
Raw vegetable consumption 76.4 68.5 84.3
No raw vegetable consumption 57.9 48.7 67.1
Meat consumption 73.3 65.0 81.6
No meat consumption 55.0 45.7 64.3
Potable water from well 50.0 40.7 59.3
Potable water from a tap 75.6 67.6 83.6
Gestational age: 1st trimester 87.5 81.3 93.7
Gestational age: 2nd trimester 66.1 57.2 74.9
Gestational age: 3rd trimester 68.6 59.8 77.3

Table 6. Prevalence of toxoplasmosis amongst pregnant women based on the gestational age.

T. gondii IgG
No of positives (%) No of negatives (%) Total (%)
First trimester 14(87.50) 2(12.50) 16 (14.50)
Second trimester 39(66.10) 20(33.90) 59 (53.60)
Third trimester 24(68.57) 11(31.43) 35 (31.80)
Total 77(70.00) 33(30.00) 110 (100.00)

χ2=2.7; P>0.05.

Table 1 shows the seroprevalence of toxoplasmosis amongst pregnant women classified according to age groups. The highest prevalence was found within the age range of 31–35, but this prevalence does not reach statistical significance.

Table 2 shows a higher seroprevalence of toxoplasmosis amongst pregnant women who owned cats. However, this prevalence was not statistically significant (χ2=0.48; P=0.12).

Table 2. Prevalence of toxoplasmosis amongst pregnant women based on cats' ownership.

T. gondii IgG
No of positives (%) No of negatives (%) Total (%)
Yes 45(72.58) 17(27.42) 62 (56.40)
No 32(66.67) 16(33.33) 48 (43.60)
Total 77(70.00) 33(30.00) 110 (100.00)

χ2=0.48; P=0.12.

Table 3 shows a significantly higher seroprevalence amongst pregnant women who eat raw vegetables and a lower prevalence amongst those who do not eat raw vegetables.

Table 3. Prevalence of toxoplasmosis among pregnant women based on raw vegetables consumption.

T. gondii IgG
No of positives (%) No of negatives (%) Total (%)
Yes 55(76.40) 17(23.60) 72 (65.50)
No 22(57.90) 16(42.10) 38 (34.50)
Total 77(70.00) 33(30.00) 110 (30.00)

Table 4 shows a higher seroprevalence amongst pregnant women who eat meat and a lower prevalence amongst those who do not eat meat but this higher seroprevalence did not reach statistical significance (P=0.09).

Table 4. Prevalence of toxoplasmosis amongst pregnant women based on meat consumption.

T. gondii IgG
No of positives (%) No of negatives (%) Total (%)
Yes 66(73.30) 24 (26.70) 90 (81.80)
No 11(55.00) 9 (45.00) 20 (18.20)
Total 77(70.00) 33 (30.00) 110 (100.00)

Table 5 shows that the seroprevalence of toxoplasmosis is significantly higher amongst those pregnant women whose source of drinking water is from a general network and significantly lower amongst those whose source of water is other than the general network such as bottled water (P=0.03).

Table 5. Prevalence of toxoplasmosis amongst pregnant based on the source of drinking water.

T. gondii IgG
No of positives (%) No of negatives (%) Total (%)
Other 12(50.00) 12(50.00) 24 (21.80)
General network 65(75.60) 21(24.40) 86 (78.20)
Total 77(70.00) 33(30.00) 110 (100.00)

χ2=5.63; P=0.03.

A summary of risk factors to toxoplasmosis in pregnancy in the general Hospital DOUALA, Cameroon is presented in Table 7. The study showed the role of age, cat ownership, consumption of raw vegetables, source of potable water, meat consumption, and gestational age as risk factors for toxoplamosis in pregnancy. This table shows the risk factors of toxoplasmosis and their confidence intervals. The lower and upper limits of these confidence intervals are so closed indicating that the results were correctly measured and that toxoplasmosis is a major public health problem among pregnant women in Cameroon.

Discussion

Toxoplasmosis is an asymptomatic infection that can have severe consequences if pregnant women become infected. It is thus very essential to determine whether the infection is recent. Traditionally, screening for toxoplasmosis has been carried out in France7 and Austria8 as a mandatory part of prenatal care. Prenatal screening has also been carried out in pilot projects in countries such as Finland,9 Sweden10 and Brazil.11 This should also be implemented in developing countries looking at the prevalence (70%) obtained in this study. A wide variability in the seroprevalence of T. gondii amongst pregnant women has been reported worldwide. A decrease in the prevalence of the infection has been reported in developed countries as in the United States, where several studies have shown a clear decrease in seroprevalence in several geographic localities. A recent experience in the central valley region of Costa Rica revealed a decrease in seroprevalence from more than 70% in the 1980's to 58% in 2003. When this data was compared with those reported in the 1985 survey in the western part of Cameroon (prevalence of 48.5%)5 an increase in seroprevalence was noted, as compared with this study revealed (70%). The observed seroprevalence in this study did not depend on age but was higher in women aged between 31–35 years old. This is in contrast with the research done in California, which showed a significantly higher prevalence with increasing age.6 Seroprevalence was found to be associated to the different drinking water source in the current study. The highest prevalence (75.58%) was in people having as source of drinking water the general network supply. The higher seroprevalence in general network water users may be in accordance with a work published by Bowie et al., who indicated the presence of oocysts in chlorinated network water.12 The general network supply of water in our cities is generally not well treated and whose supply is generally erratic. The lower prevalence in people using other sources of water such as bottle water users might be explained in that the containers are filled soon after the water surfaces. Oocyst forms of T. gondii seem to be the major factor in the infection of water resources.12 Considering the abundance of domestic and stray cats in the country, the consumption of uncooked vegetables and the suitable climatic conditions for sporulation of T. gondii oocysts, it seems exposure to cat faeces is the principal route for toxoplasma infection in most parts of the country. Although cats are the primary source of oocysts that cause human and livestock infections,13 in our study, household cats were not found to be significantly associated with T. gondii infections in pregnant women. This could therefore be due to the consumption of raw vegetables as a significant high prevalence amongst those who eat raw vegetables not properly washed. The finding correlates with an earlier report in Trinidad and Tobago.14 Oocysts are not found on cats' fur and are often buried in soil along with cats' faeces, and soil contact is universal and difficult to avoid. Vegetbles sold in our markets are usually displayed on plain ground, with the possibility of contamination with cats faeces. Exposure to infected meat could be a risk factor as well, but from this study there was no significant prevalence with meat consumption and a similar situation was observed in Colombia.6 The convention here is to eat meat that has been well cooked. This study showed that the 70% of the pregnant women had a latent T. gondii infection based on the presence of IgG antibodies while 2.73% of the pregnant women had an acute infection based on the presence of IgM antibodies. Therefore there is a high risk of transplacental vertical transmission to the fetus in women with IgM antibodies. This study also showed that raw vegetable consumption and the use of general network as source of drinking water are risk factors that can be associated with toxoplasmosis in pregnant women attending the Douala General Hospital in Cameroon.

References

  • 1.Koneman EW, Allen SD, Janda WM, Schereckenberger PC, Winn WC. J.B. Lippincott Co.; Philadelphia, PA, USA: 2004. Introduction diagnostic microbiology. [Google Scholar]
  • 2.Gratzl R, Sodeck G, Platzer P, et al. Treatment of toxoplasmosis in pregnancy: concentrations of spiramycin and neospiramycin in maternal serum and amniotic fluid. Eur J Clin Microbiol Infect Dis. 2002;21:12–16. doi: 10.1007/s10096-001-0644-6. [DOI] [PubMed] [Google Scholar]
  • 3.Montoya JG, Remington JS, Contopoulos-Ioannidis D. Laboratory Tests for the Diagnosis of Toxoplasmosis: A Guide for Clinicians. Palo Alto Medical Foundation. 2011 Available from: http://www.pamf.org/serology/clinicianguide.html.
  • 4.Jones JL, Kruszon-Moran D, Wilson M. Tooxoplasma gondii infection in the United States, 1999–2000. Emerg Infect Dis. 2003;9:1371–4. doi: 10.3201/eid0911.030098. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Marty P, Reynes J, Le Fichoux Y. Study of toxoplasmosis in pregnant women in Cameroon. Bull Soc Pathol Exot Filiales. 1985;78:623–8. [Article in French] [PubMed] [Google Scholar]
  • 6.Remington JS, McLeod R, Thulliez P, Desmonts G. Toxoplasmosis. In: Remington JS, Klein J, editors. Infectious diseases of the fetus and newborn infant. 6th edition. Elsevier Saunders; Philadelphia, PA, USA: 2006. [Google Scholar]
  • 7.Baril L, Ancelle T, Goulet V, et al. Risk factors for Toxoplasma infection in pregnancy: a case-control study in France. Scand J Infect Dis. 1999;31:305–9. doi: 10.1080/00365549950163626. [DOI] [PubMed] [Google Scholar]
  • 8.Aspök H, Pollak A. Prevention of prenatal toxoplasmosis by serological screening of pregnant women in Austria. Scand J Infect Dis Suppl. 1992;84:32–7. [PubMed] [Google Scholar]
  • 9.Lappalainen M, Koskela P, Hedman K, et al. Incidence of primary toxoplasma infection during pregnancy in southern Finland: a prospective cohort study. Scand J Infect Dis. 1992;24:97–04. doi: 10.3109/00365549209048407. [DOI] [PubMed] [Google Scholar]
  • 10.Ahlfors K, Börjeson M, Huldt G, Forsberg E. Incidence of toxoplasmosis in pregnant women in the city of Malmö, Sweden. Scand J Infect Dis. 1989;21:315–21. doi: 10.3109/00365548909035702. [DOI] [PubMed] [Google Scholar]
  • 11.Neto EC, Anele E, Rubim R, et al. High prevalence of congenital toxoplasmosis in Brazil estimated in a 3-year prospective neonatal screening study. Int J Epidemiol. 2000;29:941–7. doi: 10.1093/ije/29.5.941. [DOI] [PubMed] [Google Scholar]
  • 12.Bowie WR, King AS, Werker DH, et al. Outbreak of toxoplasmosis associated with municipal drinking water. Lancet. 1997;50:173–7. doi: 10.1016/s0140-6736(96)11105-3. [DOI] [PubMed] [Google Scholar]
  • 13.Parvin JK, Clark LM. Saunders Publ.; London, UK: 1987. Clinical medicine: a text book for medical students and doctors. [Google Scholar]
  • 14.Cook AJ, Gilbert RE, Buffalano W. Sources of toxoplasma infection in pregnant women: a European multicentre case-control study. European Research Network on Congenital Toxoplasmosis. BMJ. 2000;321:142–7. doi: 10.1136/bmj.321.7254.142. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Public Health in Africa are provided here courtesy of AOSIS

RESOURCES